ferric citrate has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, E; Chua, AC; Ingram, HA; Raymond, KN | 1 |
| Morgan, E; Trinder, D | 1 |
2 other study(ies) available for ferric citrate and Liver Neoplasms
| Article | Year |
|---|---|
Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Topics: Animals; Deferiprone; Deferoxamine; Ferric Compounds; Hepatocytes; Iron; Iron Chelating Agents; Iron Radioisotopes; Kinetics; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Molecular Structure; Pyridones; Rats; Rats, Wistar; Tumor Cells, Cultured | 2003 |
Mechanisms of ferric citrate uptake by human hepatoma cells.
Topics: 2,2'-Dipyridyl; Binding Sites; Biological Transport; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Membrane; Chelating Agents; Ferric Compounds; Humans; Iron; Iron Radioisotopes; Kinetics; Liver Neoplasms; Phenanthrolines; Time Factors; Tumor Cells, Cultured | 1998 |